Commercial strategy and advisory services designed with the needs of emerging pharma in mind
Sutton Lane is a boutique consulting firm focused on addressing the commercial needs of small, emerging pharmaceutical and biotech companies. We develop innovative strategies to support your assets prior to approval through successful launch. We advise companies on portfolio management, product acquisition, and licensing opportunities acting as the commercial voice of your due diligence team.
About
The fundraising landscape continues to be a challenge for emerging companies advancing clinical stage assets. Savvy executives understand commercial strategy is paramount to attract investors and to deliver financial results. Anne Kirby established Sutton Lane to offer a solution to emerging pharmaceutical and biotech companies so they may demonstrate market preparedness without the commitment and expense of an employed team.
​
Anne has over ten years of experience leading the buildout and strategic direction of commercial functions within emerging companies. She is a student of the healthcare industry with a fluent understanding of the dynamics that support or limit access to therapeutic interventions. Anne has a strong track record of developing and implementing inventive marketing, sales, and patient service models that optimize return.
Implementation
Solutions
Strategy
We believe every market is unique, particularly in rare and orphan diseases. Our approach starts with understanding the landscape and the patient journey. We develop commercial strategies that integrate the interests of patients, providers, and payors to increase access to care and drive adoption.
We can operate as an extension of our clients to implement commercial strategies and manage day-to-day business operations.
Advisory Services
Our passion is driving scientific advancement through market adoption. We offer advice in areas of portfolio management, lifecycle management, product acquisition, and licensing. Sutton Lane can act as the commercial voice of your due diligence team.